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Arachidonate and medium-chain fatty acids inhibit
transcription of the acetyl-coA carboxylase gene
in hepatocytes in culture
E Bradley HiUgartner' and Tina Charron
Department of Biochemistry, School of Medicine, West Virginia University, Morgantown, WV 26506

Abstract Transcription of acetyl-CoA carboxylase in avian
liver is low during starvation or after consumption of a lowcarbohydrate, high-fat diet and high during consumption of a
high-carbohydrate, low-fat diet. The role of fatty acids or metabolites derived from fatty acids in the nutritional control of
acetyl-coA carboxylase transcription was investigated by determining the effects of long- and medium-chain Fatty acids
on acetyl-coA carboxylase expression in primary cultures of
chick embryo hepatocytes. Palmitate, oleate, and arachidonate caused a decrease in acetyl-coA carboxylase activity in
hepatocytes incubated with triiodothyronine (T3). The inhibition of acetyl-coA carboxylase activity caused by arachidoiiate was accompanied by a similar decrease in transcription
of the acetyl-coA carboxylase gene. In contrast, neither palmitate nor oleate were effective in modulating ac
hoxylase transcription. These results are cot
ardchidonate or a metabolite derived therefrom mediating
the effects of diets containing high levels o f n-6 polyunsaturated fatty acids on acetyl-coA carboxylase transcription in
liver. Hexanoate and octanoate also inhibited acetyl-coA carboxylase activity in the presence of T3. The magnitude of thr
hexanoate- or octanoate-induced decrease in acetyl-CoA cai-boxylase activity was greater than that observed for long-chain
fatty acids. Hexanoate and octanoate inhibited acetyl-CoA
carboxylase activity at a transcriptional step, and did s o within
2 h of addition of fatty acid. Addition 01 carnitine partially reversed the inhibitory effects of octanoate on acetyl-coA carboxylase expression, suggesting that a metabolite of octanoatc
is involved in mediating this response. 2-Bromooctanoate was
a more potent inhibitor of acetyl-CoA carboxylase expression
than octanoate or hexdn0ate.m M% postulate that a metabolite of hexanoate and octanoate, possibly a six or eight carhon
acyl-CoA, plays a role in the nutritional regulation of acctylCoA carboxylase transcription.-Hillgartner,
F. B., and T.
Charron. Arachidonate and medium-chain fatty acids inhibir
transcription of the acetyl-coA carboxylase gene in hepatocytes in culture.,/. Lijiid Krr. 1997. 38: 2548-2557.
Supplementary key words tranrcription
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fatty acid synthesis

thy-

Acetyl-CoA carboxylase (EC 6.4.1.2) catalyzes the
ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA which is the donor of all but two (omega) o f
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the carbon atoms for the synthesis of long-chain fatty
acids. This reaction is considered a pace-setting step of
the fatty acid synthesis pathway (1) . In the liver of avians and mammals, the activity of acetyl-coA carboxvlase is regulated by alterations in nutritional status.
Short-term changes in enzyme activity are mediated by
allosteric and covalent modification mechanisms (1-3).
Acetyl-coA carboxylase activity is also controlled by
long-term alterations in enzyme concentration. For example, the concentration of acetyl-CoA carboxylase in
liver is low in starved chickens and rats; feeding a highcarbohydrate, low-fat diet stimulates an 8- to 20-fold increase in the amount of the enzyme (4-8). The composition of the diet also regulates the concentration of hepatic acetyl-CoA carboxylase. In chickens and rats fed a
low-carbohydrate, high-fat diet, the level of acctyl-CoA
carboxylase is substantially reduced compared to that
of animals fed a high-carbohydrate, low-fat diet (9-12).
Changes in acetyl-ChA carboxylase concentration
caused by nutritional manipulation are accompanied
by coniparable alterations in the synthesis rate and
mRNA abundance for acetyl-CoA carboxylase, indicab
ing that regulation occurs at a pretranslational step (59, 13-16). The effects of dietary manipulation on
acetyl-CoA carboxylase mRNA abundance are mediated primarily by changes in the transcription rate o f
the acetyl-CoA carboxylase gene ( 1 4 ) .
Several lines of evidence indicate that glucose, instilin, 3,5,3'-triiodothyronine (T3), and glucagon are humoral factors that communicate changes in nutritional
status to the liver, thereby mediating nutritional regulation of hepatic acetyl-coA carboxylase. First, the stimiilation i n acetyl-CoA carboxylase transcription caused by

Abbreviations: T3, 3,.5,3'-triiodo-1.-thyroninr.
'To whom correspondence should be addi-essetl

feeding a high-carbohydrate, low-fat diet is preceded or
paralleled by increases in the molar ratio of insulin/
glucagon and the levels of glucose and T3 in the blood
(17). Second, glucose, insulin, T3, and glucagon regulate acetyl-coA carboxylase transcription in primary
cultures of chick embryo hepatocytes. T3 stimulates a 3fold increase in the transcription of acetyl-coA carboxylase gene (18). Glucose (20 mM) has no effect by itself
on acetyl-coA carboxylase transcription but amplifies
the effect of T3 by 3-fold. Insulin accelerates the increase in acetyl-coA carboxylase transcription caused
by T3 and glucose, whereas glucagon inhibits the stimulatory effect of T3 and glucose by 65%.
Fatty acids or metabolites derived from fatty acids
may also participate in the nutritional regulation of
acetyl-coA carboxylase. Saturated, monounsaturated,
and polyunsaturated long-chain fatty acids cause a decrease in the concentration and rate of synthesis of
acetyl-CoA carboxylase in rat hepatocyte cultures (19,
20). This finding coupled with the observation that levels of unesterified long-chain fatty acids in the blood
and liver are elevated during starvation or high-fat
feeding (21, 22) suggest that these agents may signal
alterations in nutritional state to the liver. In the
present study, we investigated this possibility further by
determining the effects of palmitate, oleate, and
arachidonate on the transcription rate of the acetylCoA carboxylase gene in chick embryo hepatocytes.
We show that arachidonate inhibits transcription of
acetyl-coA carboxylase in the presence of T3, whereas,
palmitate and oleate are not effective in regulating the
transcription of this gene. We also demonstrate that
six- and eight-carbon fatty acids are potent inhibitors
of acetyl-coA carboxylase transcription. We postulate
that a metabolite derived from these fatty acids plays a
role in the nutritional regulation of acetyl-coA carboxylase transcription.

MATERIALS AND METHODS

Chemicals
Nucleotides (Pharmacia Biotechnology), proteinase
K (Boehringer Mannheim), fatty acids (Nu Chek
Prep), [ a-32P]UTP and [o~-~*P]
dCTP (ICN Biomedicals) were purchased from the indicated sources. Crystalline bovine insulin was a gift from Lilly. Bovine serum albumin deficient in unesterified fatty acids was
obtained from ICN Biomedicals. All other chemicals
were from Sigma or of the highest purity commercially
available.

Preparation and maintenance of isolated hepatocytes
Unincubated embryonated eggs from white Leghorn
chickens were obtained from Truslow Farms, Chestertown, MD and incubated in an electric forced draft incubator at 37.5 t- 0.5% and 80% relative humidity. Embryos (19 days of age) were killed by decapitation, the
livers were removed, and hepatocytes were isolated
(23). The isolated hepatocytes were incubated in Waymouth’s medium MD705/1 (GIBCO) containing penicillin (60 pg/ml) and streptomycin (100 p,g/ml) on
untreated plastic Petri dishes (Fisher) at 40°C in a humidified atmosphere of 5% COBand 95% air. One 90mm Petri dish contained 1 ml of cell suspension (2-3
mg total protein, approximately 1 X lo7 cells) and 9 ml
of medium. The medium on all plates was changed after about 18 h of incubation. Hormone and other additions were as described in the legends to figures and tables. Palmitate, oleate, and arachidonate were bound
to albumin as described by Mooney and Lane (24).
Acetyl-coA carboxylase activity was measured as described by Salati and Clarke (19).The concentration of
citrate (10 mM) in this assay yields optimal product formation and reverses the inhibitory effects of long-chain
fatty acids on acetyl-coA carboxylase activity (25, 26).
Protein was measured as described (27). We chose
arachidonate to study the effects of polyunsaturated
fatty acids on acetyl-coA carboxylase expression because previous studies have shown that hepatocytes in
primary culture have a limited ability to desaturate and/
or elongate linoleate which is essential for linoleateinduced inhibition of expression of lipogenic enzymes
(28, 29).

Isolation of RNA and quantitation of mRNA levels
Medium was removed and RNA was extracted from
cells by the guanidinium thiocyanate/phenol/chloroform method (30). Total RNA (15 kg) was separated by
size in 0.9% agarose, 0.7 M formaldehyde gels, and then
transferred to a Nytran membrane (Schleicher &
Schuell) using a vacuum blotting apparatus (Pharmacia Biotechnology). The RNA was crosslinked to the
membrane by UV and baked at 80°C: for 30-60 min.
RNA blots were hybridized with 32P-labeled DNA
probes labeled by random priming (31). Hybridization
and washes were as described (32). Membranes were
subjected to storage phosphor autoradiography. Hybridization signals were quantified using ImageQuant
software (Molecular Dynamics).

Nuclear run-on assay of transcription rates
Nuclei were isolated from the pooled cells of 15 90mm plates (33, 34). Approximately 5 X IO7 nuclei were
stored at -80°C in 100-pl aliquots containing 50 mM
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HEPES, pH 7.4, 75 mM NaCl, 0.1 mM EDTA, 5 mM
dithiothreitol, 0.125 mM PMSF, and 50% glycerol. The
in vitro elongation reactions were carried out as
described ( 1 4, 35). 32P-labeled RNA transcripts were
purified by the method of Linial, Gunderson, and
Groudine (36), using NICK columns (Pharmacia
Biotechnology) as described in the manufacturer's instructions. Denaturation of DNA probes, application of
DNA to Genescreen membranes, hybridization of 32Plabeled RNA transcripts to membrane-bound DNA,
and posthybridization washes were carried out as described (14). Hybridization signals were quantified as
described above.

DNA probes
Three non-overlapping cDNA fragments of chicken
acetyl-coA Carboxylase were used as transcription
probes in the nuclear run-on assay. ACC-1, ACC-2, and
ACC-3 correspond to bases 151 to 2075, 2283 to 4486,
and 5019 to 6926, respectively, of the chicken acetylCoA carboxylase cDNA sequence reported by Takai et
al. (37). These cDNA fragments are located within the
coding region (see Fig. 1C) and encode the 265 kDa
isoform of acetyl-coA carboxylase, the only isoform of
the enLyme expressed in chicken liver (38). All three
acetyl-CoA carboxylase cDNA probes hybridize to two
mRNAs of 10 and 11 kb on Northern blots of chick embryo hepatocyte RNA. Based on Southern analysis of
genomic DNA, ACC-1, ACC-2, and ACC-3 are unique
and do not contain repetitive sequences (14). Nuclear
transcripts generated during in vitro elongation hybridized only to the coding- strand of each acetvl-CoA carboxylase probe, indicating that transcription was
strand-specific. Each probe was subcloned into a Bluescript (Stratagene) vector. The chicken cDNAs for glyceraldehyde-3-phosphate dehydrogenase, and @-actin
were generously provided by Robert Schwartz (Baylor
College of Medicine) and Don W. Cleveland (.Johns
Hopkins University), respectively.

RESULTS

Action of long-chain fatty acids
Palmitate and oleate are the major species of nonesterified free fatty acids present in the plasma arid
liver of avians (22). The levels of these fatty acids are
regulated by changes in nutritional status. The concentrations of palmitate and oleate in plasma and liver
are high in starved chicks and are low in chicks fed a
high-carbohydrate, low-fat diet. These alterations in
the levels of palmitate and oleate are mediated primar-
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ily by changes in the rate of lipolysis in adipose tissue
(39). To investigate whether palmitate and oleate are
involved in mediating changes in hepatic acetyl-CoA
carboxylase expression caused by starvdtion/refeeding, we determined the effects of these fatty acids on
the activity of acetyl-coA carboxylase in chick embryo
hepatocytes incubated in the presence of insulin (50
nM) and glucose (27.5 mM) with or without T3 (1.5
p ~ )Addition
.
of albumin-bound palmitate or oleate to
the culture medium inhibited the T3-induced increase
in acetyl-coA carboxylase activity in a concentrationdependent manner (Table 1 ) . At a concentration of
250 y h r , the inhibition by palmitate and oleate was
about 35%. Palmitate and oleate had 110 effect o n
acetyl-coA carboxylase activity i n the absence o f T3.
We also investigated the effects of arachidonate on
acetyl-coA carboxylase activity because increasing thy
level of polyunsaturated fat in the diet causes a dccrease in acetyl-coA carboxylase expression in chicks
and rats (14, 40). Addition of arachidonate at 100 and
250 p~ inhibited the T3-induced increase in acetylCoA carboxylase activity by 32 and 45%. respectively
(Table 1). Arachidonate had no effect on acetyl-CoA
carboxylase activity in the absence of T3. The above
data indicate that long-chain fatty acids of differing levels of saturation are able to inhibit acetyl-CoA carboxylase activity in chicken embryo hepatocyte cultures.
These changes in acetyl-coA carboxylase activity caused

TABLE 1. 1,ong-chain fatty acids inhibit the T3-intlucrd
increase in acetyl-ChA (hrhoxyiase Activity
..

-

.

~

-

~

.

-1 %
.

t

~ - .

Fatty acld-tlee albumin (1 i p h ~ )
PAhLate ( 100 W )
Oleate ( I 00 J L V )
-\rachldonnte (
phl)
F'itty xid-free albumin (42 pu)
Palmitate (250 *hI)
OlC'Att. (250 p Z 1 )
-\i,ichtdon,itc (250 J L N )

100

N 11

N I)
N 1)
h 1)
If12 t 'I
l'I8-i-2
15522
l(1N-t I

I?

81

r 5"

io

_f

x

(18 ? 4"
00 i x

02
(1;

5

+

5'

i 10'
i '4

Hepatocytes were isolated as described under Materi;tls and
Methods ant1 incubated in Waytnouth's mediurn containing insulin
(50 n ~ and
) 27.5 nisi gluc(ise. At 18 h of incubation, the rnediunr was
changed to onc of the same composition with or without T3 (1.5 p v ) .
Palmitate, oleate, and arachidonate were added at this time. The roilcentration of thc fatty acids was 100 and 250 P S I .The cortesponding
albumin roncentrations were 17 and 42 p.~, respectively. Controls
were treated with Fatty acid-free albumin alonc. At about 42 h ofinciibation, the medium was changed to one of the same comporiLiorl.
The cells were hat-vested at 66 11 of incubation and acetyl-CoA carboxylase activity was measured. The results are expressed ;LC p e r r c n t a p
of the value f or cells incubated with 1'3 and 17 p~ albumin 2 v t ol
three experiments. 100 = 32 ? 2 mU/mg pi-otein.
Supersci-ipt le~tersindicatc significant differences (I' < 0.05) a s
determined by Student's t-test: "versus 17 PM Fatty acid-free dbumiii:
' I I S 42 p h i fatty acid-free albumin. NU, nut determined.

by long-chain fatty acids reflect alterations in the
amount of acetyl-coA carboxylase because the activity
of the enzyme was measured in the presence of citrate
under optimal conditions (19).
To determine the mechanism for changes in acetylCoA carboxylase activity caused by long-chain fatty acids, mRNA abundance and transcription of acetyl-coA
carboxylase was measured. Incubating hepatocytes
with palmitate o r oleate at a concentration of 250 p~bl
for 48 h had no effect o n the accumulation of acetylCoA carboxylase mRNA caused by TS (Fig. 1A). Palmitate and oleate also had n o effect of the transcription
rate of the acetyl-coA carboxylase gene under conditions where hepatocytes were incubated with TS for 29
h and fatty acids were added at a concentration of 250
p h i (Fig. 1B) o r 500 p~ (results not shown) during the
last 5 h of the incubation with TS. Similar results were o h
tained when palmitate o r oleate (250 p ~ were
) added
at the same time as TS and incubated for 29 h (results
not shown). These data indicate that the inhibitory effects of palmitate and oleate on the level of acetyl-coA
carboxylase are not mediated by a pretranslational
mechanism. T h e lack of effect of palmitate on the
mRNA abundance and transcription of acetyl-coA carboxylase is not due to a lack of metabolism of this fatty
acid because palmitate in the medium is rapidly converted to COPand intracellular lipids in chick embryo
hepatocytes (23). In contrast to the actions of palmitate and oleate, addition of arachidonate (250 p ~ in)
hibited the TS-induced accumulation of acetyl-CoA
carboxylase mRNA by 44 ? 6% (Fig. 1A). Arachidonate also decreased the transcription of the acetyl-coA
carboxylase gene when it was added during the last 5 h
of a 29-h incubation with TS. The extent of the decrease in acetyl-coA carboxylase transcription as
detected by the 5’-most acetyl-coA carboxylase cDNA
probe (ACGl) was 47 ? S and 51 ? 8% when arachidonate was added at a concentration of 250 p~ (Fig.
1B) and 500 phi (results not shown), respectively. Similar changes in acetyl-coA carboxylase transcription
were observed with acetyl-coA carboxylase probes
from the middle (ACC-2) and 3’ (ACCS) portions of
the cDNA. These data indicate that the effects of arachidonate on acetyl-coA carboxylase activity are accounted for by changes in acetyl-coA carboxylase
mRNA abundance, which in turn, are due primarily to
changes in acetyl-coA carboxylase transcription. T h e
effects of arachidonate o n acetyl-coA carboxylase transcription were specific because transcription of the
genes for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and p-actin were not affected by this fatty
acid (Fig. IB).
Long-chain fatty acids have been reported to inhibit
the binding of TS to its nuclear receptor in vitro by a

competitive mechanism (41, 42). In the experiments
described above, hepatocytes were incubated with a
concentration of TS (1.5 p ~ that
) was about lo3 times
higher than that required to saturate the nuclear TS re-
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Fig. 1. Effects of long-chain Fatty acids o n the mRNA abundance (A) and transcription (B) of acetyl-coA carboxylase. Hepatocytes were isolated and incubated in Waymouth’s medium containing insulin and 27.5 m\i glucose. At 18 h of incubation, the
medium was changed to one of the same composition with or
without TS (1.5 pci). In A, albumin-bound palmitate (C160), oleate (C18:l). or arachidonate (C20:4) were added at this time. The
Concentration of the fatty acids was 250 p ~ Controls
.
were treated
with fatty acid-free albumin (42 pv). At about 42 h of incubation,
the medium was changed to one of the same composition. The
cells were harvested at 66 h of incubation and acetyl-coA carboxylase mRNA levels were measured by Northern analysis as described under Material and Methods. In B, fatty acids (250 p ~ )
were added at 42 h of incubation without medium change and
the incubation was continued for 5 h. Nuclei were isolated, and
acetyl-CoA carboxylase transcription was measured by nuclear
run-on assay as described under Materials and Methods. The
acetyl-CoA carboxylase cDNA fragments that were used as probes
in the nuclear run-on assay are shown in C. The stippled rectangle
represents the coding sequence of the acetyl-CoA carboxylase
cDNA. The experiments in A and B were repeated three times
with similar rcsults.
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ceptor. This level of hormone was used in long-term incubations to ensure that optimal levels of T3 were
present throughout the incubation as T3 is degraded
rapidly in serum-free Waymouth's medium (43). Because high T3 concentrations may mask a possible
inhibitory effect of long-chain fatty acids on acetylCoA carboxylase expression, the effect o f palmitate on
acetyl-coA carboxylase transcription was also determined in hepatocytes incubated with 20 nM T3. The
transcription rate of acetyl-coA carboxylase in hepatocytes incubated with 20 nM T3 for 29 h was 49% of that
observed in cells incubated with 1.5 ~ L T3
M (Fig. 2). Addition of palmitate (250 p ~ during
)
the last 5 h of the
incubation with 20 nv T3 had n o effect o n acetyl-coA
carboxylase transcription. Thus, palmitate is not effective in regulating acetyl-coA carboxylase transcription
in the presence of optimal o r suboptimal T3 levels.
Competitive interactions between T3 and palmitate for
binding to nuclear T3 receptors d o not appear to be
involved in the regulation of acetyl-coA carboxylase in
intact hepatocytes.

ACC-1
ACCP
ACC-3

Action of mediumchain fatty acids
In a previous report (44), unesterified mediumchain
fatty acids were shown to cause a marked inhibition in
the expression of the genes for malic enzyme and fatty
acid synthase. This prompted u s to investigate the effects of mediumchain fatty acids o n the activity of
acetyl-coA carboxylase in chick embryo hepatocytes.
Mediumchain fatty acids are much more soluble in
aqueous medium than long-chain fatty acids. Thus, we
were able to test the effects of mediumchain fatty acids
without binding them to albumin. Incubating hepatocytes with hexanoate and octanoate (1 m u ) in the presence of T3, insulin, and glucose (27.5 mw) for 72 h
caused a 70 and 79% decrease in acetyl-coA carboxylase activity, respectively (Table 2). Butanoate and decanoate also inhibited the TSinduced increase in
acetyl-coA carboxylase activity, but to a significantly
lesser extent. In the absence of T3, addition of
mediumchain fatty acids had no effect on acetyl-coA
carboxylase activity. Thus, mediumchain fatty acids inhibit the TSinduced increase in acetyl-coA carboxylase
activity, and fatty acids of six to eight carbons in chain
length are most effective in causing this effect.
To determine the mechanism for the effects of hexanoate and octanoate on acetyl-coA carboxylase activity, acetyl-coA carboxylase mRNA levels were measured
in chicken embryo hepatocytes incubated with different concentrations of these fatty acids. Both hexanoate
and octanoate caused a dose-dependent decrease in
the accumulation of acetyl-coA carboxylase mRNA
caused by T3 (Fig. 3A). Maximal inhibition of acetylCoA carboxylase mRNA abundance by hexanoate
and octanoate was 75 ? 9 and 85 5 6%, respectively,

Vector
GAPDH
P-Actin
Eg.
- 2. Effect of palmitate on the transcription of the acetvl-CoA
carboxylase gene in hepatocytes incubated with 20 nai or 1.5 psi
T3. Hepatocytes were isolated and incubated in Waymouth's me-

TARLE 2. Mediumchain Fatty acids inhibit the T3-induced
increase in acetyl-CoA carboxylase activity
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56 2 4"
dium containing insulin and 27.5 msi glucose. At 18 11 of incitbaHcxanoate
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821
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11 2 2
67 ? .if'
At 30 h of incubation, the medium was changed to o n e of the
same composition. At 42 h of incubation, albumin-bound palmiHepatocytes were isolated and incubated in Waymouth's medium containing insulin (50 nil) and 27.5 mil glucose. At 18 ti of intate (2.50 p h i ) was adclecl iGtl1olit medium clialige. Controls were
cuhation. the mediiiin was changed to one of the same composition,
,& 47 1, of inCubatreater1
fattv-acid free albumin (42
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isolated, ancl a c e t y l - ~ o ~carboxylase transcrip
tioll, nrlc~ei
abollt 66 h of incubation. the Incdium was changed to olic of thc
tion ,vas measuredby nuclear run-onassay as described
Masame composition. The cells were han~estetlat 90 h of incubation and
terials and Methods. ,411 probes on each strip were Iiybriclized with
acetyl-CoA
activity was measured.
results arc exthe same preparation of :l"P-laheled RNA transcript5 a t the same
pressed as perccntagcs oftlie v;llue for cellsincubated with T3 and
time; strips of prints of the ailtoradiograph were reorganized to
fatty acids 2 St (,ftilree cxperil,,cnn~
100 = 38 2 3
protein,
maintain the same order of probes in all figures. This experiment
"Mean is difrcrent ( P < 0.01) from that o f cells treated with no
was repeated twice with similar results.
fatty acids as determined by Student's /-test.
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Fig. 3. Effects of six- and eightcarbon fatty acids on the abrindance of acetyl-CoA carboxylase mRNA as function of concentration (A) and the presence o r absence of carnitine (B). Hepatocytes were isolated a n d incubated in Waymouth's medium
containing insulin and 27.5 m u glucose. At 18 h of incubation,
the medium was changed to one of the same composition and TJ
(1.5 )*.%I) was added with o r without hexanoate, octanoate, o r 2bromooctanoate at the indicated concentrations. In ( B ) , carnitine ( 5 mu) was added at this time. The cells were harvested 48
h later and acetyl-CoA carboxylase mRNA levels were measured by
Northern analysis as described under Materials and Methods. The
experiments in A and B were conducted a total of four and three
times, respectively, with similar results.

and was observed at a concentration of 1 mbi. These
data indicate that hexanoate and octanoate act at a pretranslational a step to inhibit acetyl-coA carboxylase
levels.
To assess the role of transcription in mediating the
inhibition of acetyl-coA carboxylase mRNA levels by
mediumchain fatty acids, nuclear run-on experiments
were performed. Addition of hexanoate or octanoate
(1 mv) during the last 2 h of a 2Sh incubation with T3
caused a marked decrease in the acetyl-coA carboxylase transcription (Fig. 4). The extent of the inhibition
of transcription as detected by ACCl was 79 5 9 and
85 ? 7% for hexanoate and octanoate, respectively.
Similar changes in acetyl-coA carboxylase transcription
were detected by ACC2 and ACC3. Thus, rapid alterations in the rate of transcription initiation of the
acetyl-coA carboxylase gene account for all of the
changes in acetyl-coA carboxylase mRNA levels caused
by hexanoate or octanoate. Butanoate (1 mbi) also inhibited acetyl-coA carboxylase transcription; the magnitude of this effect (35 ? 6% as detected by ACCl)

Fig. 4. Butanoate, hexanoate, and octanoate rapidly inhibit the
transcription of the acetyl-coA carboxylase gene. Hepatocytes
were isolated and incubated in Waymouth's medium containing
insulin and 27.5 msi glucose. At 18 h of incubation, the medium
was changed to one of the same composition and TJ (1.5 PM)was
added. At 44 h of incubation, the indicated fatty acids ( 1 msi)
were added withorit medium change and the incubation was continued for 2 h. Nuclei were isolated, and acetyl-coA carboxylase
transcription was measured by nuclear run-on assay as described
under Materials and Methods. This experiment was repeated
twice with similar results.

was less than that of hexanoate and octanoate. The effects of hexanoate, octanoate, and butanoate on acetylCoA carboxylase transcription were specific because
transcription of the genes for glyceraldehyde-3phosphate dehydrogenase (GAPDH) and p-actin were not
affected by fatty acid treatment (Fig. 4).

Evidence that a metabolite mediates the inhibition of
acetyl-coA carboxylase expression by octanoate
To investigate whether inhibition of acetyl-coA carboxylase expression by octanoate requires the metabolism of this fatty acid, we determined the effects of exogenous carnitine on acetyl-coA carboxylase mRNA
levels. Carnitine is a substrate in the transesterification
of fatty acyl-CoAs to acylcamitines, reactions catalyzed
by acylcarnitine transferases. Various forms of this
enzyme have been identified that utilize short-, medium-, or long-chain fatty acyl-CoAs (45, 46). Because
these reactions are readily reversible, addition of carnitine should increase the levels of acylcamitines and
decrease the levels of fatty acyl-CoAs via mass action.
Addition of 5 mbi carnitine to chick embryo hepate
cytes incubated in the presence of T3 and 1 mM octanoate increased the abundance of acetyl-coA carboxylase mRNA by 2.3 ? 0.4fold (Fig. 3B). Carnitine had
little or no effect on acetyl-coA carboxylase mRNA levels in cells incubated with 0 or 2.5 mM octanoate. These
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data are consistent with a metabolite mediating the
inhibition of acetyl-coA carboxylase expression by octanoate. This metabolite may be an acyl-CoA containing
six or eight carbons whose concentration is reciprocally
regulated by octanoate and carnitine. To investigate
this possibility, we examined the effects of P-bromooctanoate on acetyl-coA carboxylase mRNA levels. In
hepatocytes, 2-bromooctanoate is activated to 2bromooctanoyl-CoA and then oxidized to 2-bromo-3ketooctanoyl-CoA, an irreversible inactivator of mitochondrial and peroxisomal 3-ketothiolases I (47, 48).
2-Bromooctanoate also inhibits diacylglycerol acyltransferase in hepatocytes; 2-bromooctanoyl-CoA is the ac tive inhibitor (49). Incubating chick embryo hepatocytes with 2-bromooctanoate in the presence of T?J
caused a dose-dependent decrease in the accumulation
of acetyl-coA carboxylase mRNA (Fig. 3A). The maximal inhibition of acetyl-coA carboxylase mRNA abundance caused by 2-bromooctanoate was 83 ? 12% and
was observed at a concentration of 0.3 m ~Thus,
.
2-bromooctanoate was more potent than octanoate in inhibiting the expression of acetyl-coA carboxylase. This
result suggests that the active inhibitor may be an acylCoA containing six or eight carbons.

DISCUSSION
Unesterified long-chain fatty acids can regulate
acetyl-coA carboxylase activity in hepatocytes by modulating both the catalytic efficiency and level of expression of the enzyme. Regarding the former mode of regulation, long-chain fatty acyl-CoAs are potent allosteric
inhibitors of acetyl-coA carboxylase (25, 50, 51).
Regarding the latter mode of regulation, long-chain
fatty acids inhibit the expression of acetyl-coA carboxylase in rat (19, 20) and avian (Table l ) hepatocytes.
The results of the present study demonstrate that the
mechanism by which long-chain fatty acids inhibit expression of acetyl-coA carboxylase varies depending on
the species of fatty acid. Arachidonate acts primarily at
the level of transcription initiation to modulate acetylCoA carboxylase expression, whereas, palmitate and
oleate appear to act at a translational step (Figs. 1 and
2). Because the effects of starvation and feeding a highcarbohydrate, low-fat diet on acetyl-coA carboxylase expression are mediated primarily by changes in transcription of the acetyl-coA carboxylase gene (14), we
conclude that palmitate and oleate are not involved in
mediating these responses. This finding was not expected when one considers that palmitate and oleate
are the major species of unesterified free fatty acids
present in the liver and blood and that the levels of‘
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these fatty acids are regulated by starvation/refeeding
(22). Thus, the role of palmitate and oleate in the nutritional control of acetyl-coA carboxylase activity may
he limited to changes in the catalytic efficiency of the
enzyme. Although arachidonate is effective in regulating transcription of acetyl-coA carboxylase, its role in
mediating the effects of starvation and refeeding a
highcarbohydrate, low-fat diet on acetyl-coA carboxylase expression is unclear because arachidonate levels
in the blood and liver probably do not vary significantly
during this nutritional manipulation. Arachidonate or
metabolites derived from arachidonate may play a
greater role in mediating the inhibition of acetyl-CoA
carboxylase transcription caused by feeding high levels
of polyunsaturated fatty acids from the n-6 family ( 14).
Long-chain fatty acids have been shown to regulate
the expression of other genes involved in lipogenesis.
For example, arachidonate and other polyunsaturated
long-chain fatty acids of the n-3 and n-6 families cause
a decrease in the activities and mRNA abundance for
glucose-&phosphate dehydrogenase (L. M. Salati, personal communication), stearoyl-CoA desaturase-1 (52,
33), malic enzyme (54), fatty acid synthase (29, 54),
S14 protein (54, 55), and [.-pyruvatekinase (54, 5 6 ) in
hepatocyte cultures. In contrast, saturated and/or monounsaturated long-chain fatty acids have no effect o n
the expression of these proteins. Thus, the pattern o f
regulation of mRNA levels for acetyl-CoA carboxylase
by long-chain fatty acids appears to be similar to that of
other lipogenic enzymes. Further studies haw shown
that the effects of polyunsaturated fatty acids on mRNA
levels for stearoyl-CoA desaturase-1, [.-pyruvatekinasc,
and S14 protein are accounted for by changes in genc
transcription (52, 53, 5 5 , 56). The cisacting sequencc
in the L-pyruvate kinase gene that mediates the inhibitory effect of polyunsaturated fatty acids on i.-pyruvate
kinase transcription maps to a hepatocyte nuclear
factor-4 (HNF-4) binding site in the .5’-fhnking region
of the gene (56). Because this fatty acid regulatoiy element overlaps with sequences that mediate stimulation
of r,-pyruvate kinase transcription of glucose and insulin, polyunsaturated fatty acids may inhibit t.-pyruvatr
kinase transcription by interfering with the action of
the glucose/insulin signaling pathway. In contrast to I pyruvate kinase, sequences in the S14 gene that confer
inhibition of transcription by polyunsaturated fatty acids do not co-localize with a glucose/insulin response
element (55).The factor(s) that interacts with S14 fatty
acid response element has riot yet been identified. The
above studies suggest that several distinct mechanisms
are involved in mediating the effects of polyunsaturated fatty acids on transcription of genes involved in lipogenesis. Further analyses aimed at identifying the cisacting sequences and transacting factors that mediate

the inhibition of acetyl-coA carboxylase transcription
by arachidonate will provide additional evidence demonstrating whether common or distinct mechanisms
are involved in the transcriptional regulation of lipogenic genes by polyunsaturated fatty acids.
Previous work by other laboratories has shown that
inhibitors of arachidonate metabolism are not effective
in blocking the inhibitory effects of polyunsaturated
fatty acids on expression of fatty acid synthase and
glucose-&phosphate dehydrogenase in liver (57, 58).
Thus, products of eicosanoid synthesis do not appear
to be involved in mediating the actions of polyunsaturated fatty acids on lipogenic enzyme expression. The
identity of the active intermediate that mediates the effects of arachidonate on acetyl-coA carboxylase transcription remains to be determined.
Another significant finding of the present report is
that the medium-chain fatty acids, hexanoate and octanoate, are potent and selective inhibitors of T3induced acetyl-coA carboxylase expression in chick
embryo hepatocytes (Table 2, Figs. 3 and 4 ) . As with
arachidonate, the effects of hexanoate and octanoate
on the expression of acetyl-coA carboxylase are mediated primarily by a transcriptional mechanism. The
ability of carnitine to partially reverse the inhibition of
acetyl-coA carboxylase mRNA levels caused by octanoate suggests that the active agent is a metabolite derived from octanoate (Fig. 3B). This metabolite is likely
to be an acyl-CoA containing six or eight carbons because
2-bromooctanoate was more effective than octanoate in
inhibiting acetyl-coA carboxylase expression (Fig. 3A).
However, we cannot rule out the possibility that the active metabolite is derived from the metabolism of a six
to eight carbon acyl-CoA. 2-Bromooctanoate inhibits
and carnitine stimulates P-oxidation in hepatocytes
(24, 47, 48). Thus, the effects of 2-bromooctanoate and
carnitine on acetyl-coA carboxylase expression may not
necessarily be due to changes in the level of an acylCoA containing six to eight carbons but instead may be
mediated by another metabolite whose concentration
is controlled by rates of P-oxidation.
The mechanism(s) by which hexanoate and octanoate inhibit the T3-induced increase in transcription of acetyl-coA carboxylase is presently unknown.
Competitive interactions between these fatty acids and
T3 for binding to the nuclear T3 receptor are not involved in mediating this response because hexanoate
and octanoate have little or no effect on nuclear T3
binding activity in chick embryo hepatocytes (44).
What are other possible mechanisms through which
hexanoate and octanoate could inhibit transcription of
acetyl-coA carboxylase? One possibility is that the active metabolite of hexanoate and octanoate directly
binds to the nuclear T3 receptor and regulates its func-

tion or interacts with a nuclear protein that modulates
the transcriptional activity of the nuclear T3 receptor.
For example, the active inhibitor may be a ligand for an
as yet to be described orphan receptor that dimerizes
with the nuclear T3 receptor. Another possible mechanism is that the active metabolite of hexanoate and
octanoate triggers a phosphorylation/dephosphorylation cascade which causes an alteration in the phosphorylation state of the nuclear T3 receptor or a protein that modulates the activity of the nuclear T3
receptor. Protein phosphorylation is thought to play a
role in regulating T3 action because protein kinase inhibitors inhibit and protein phosphatase inhibitors enhance the effects of T3 on gene transcription (59,60).
Hexanoate and octanoate also inhibit transcription
of fatty acid synthase and malic enzyme in chick embryo hepatocytes (44). In contrast to our results for
acetyl-coA carboxylase, 2-bromooctanoate stimulates
the expression of fatty acid synthase and malic enzyme
in the presence of T3. The reason for the different effects of 2-bromooctanoate on acetyl-coA carboxylase
relative to fatty acid synthase and malic enzyme is not
clear. Possibly, different mechanisms are involved in
mediating the inhibition of transcription of lipogenic
enzymes by 2-bromooctanoate and octanoate.
Several lines of evidence indicate that additional factors besides glucose, insulin, T3, and glucagon are involved in mediating diet-induced changes in acetyl-coA
carboxylase expression. For example, alterations in
acetyl-coA carboxylase transcription caused by feeding
previously starved chicks a high-carbohydrate, low-fat
diet are significantly greater than those observed in
chick embryo hepatocytes caused by manipulating the
concentrations of glucose, insulin, T3, and glucagon in
the culture medium (14, 18). A role for additional factors is also indicated by the observation that changes in
the levels of insulin, T3, and glucagon in the blood
caused by starvation/refeeding are substantially smaller
than those that are needed to maximally regulate
acetyl-coA carboxylase transcription in chick embryo
hepatocytes (17). Hexanoate and octanoate per se are
not likely to play a role in mediating diet-induced
changes in acetyl-coA carboxylase transcription because these fatty acids are not present in significant
amounts in cellular or dietary lipids (61). Nevertheless,
the potent, rapid, and selective effects of hexanoate
and octanoate on acetyl-coA carboxylase transcription
suggest that the active metabolite(s) mediating the action of these fatty acids may play a role in the physiological regulation of this enzyme. For example, the concentration of the active metabolite may be regulated by
an unidentified humoral factor that is involved in mediating changes in acetyl-coA carboxylase transcription
caused by nutritional manipulation. To test this hypoth-
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esis, the identity of the active intermediate must be further defined. One approach to this problem is to trace
the intracellular signaling pathway for hexanoate and
octanoate from target sequences in the acetyl-coA carboxylase gene to the active metabolite. Studies aimed at
characterizing the cis-acting elements mediating the effects of hexanoate and octanoate on acetyl-coA carboxylase transcription in hepatocytes are currently in
pr0gress.m
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